BJSM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Sports Medicine 2006;40(Supplement 1 ):i16-i20; doi:10.1136/bjsm.2006.027557
Copyright © 2006 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avois, L
Right arrow Articles by Saugy, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avois, L
Right arrow Articles by Saugy, M

SUPPLEMENT

Central nervous system stimulants and sport practice

L Avois, N Robinson, C Saudan, N Baume, P Mangin, M Saugy

Swiss Laboratory for Doping Analyses, Institute of Legal Medicine, Lausanne, Switzerland

Correspondence to:
Correspondence to:
L Avois
Swiss Laboratory for Doping Analyses, Lausanne University, Switzerland; lidia.avois{at}chuv.ch

Background and objectives: Central nervous system (CNS) stimulants may be used to reduce tiredness and increase alertness, competitiveness, and aggression. They are more likely to be used in competition but may be used during training to increase the intensity of the training session. There are several potential dangers involving their misuse in contact sports. This paper reviews the three main CNS stimulants, ephedrine, amfetamine, and cocaine, in relation to misuse in sport.

Methods: Description of the pharmacology, actions, and side effects of amfetamine, cocaine, and ephedrine.

Results: CNS stimulants have psychotropic effects that may be perceived to be ergogenic. Some are prescription drugs, such as Ephedra alkaloids, and there are issues regarding their appropriate therapeutic use. Recently attention has been given to their widespread use by athletes, despite the lack of evidence regarding any ergogenic or real performance benefit, and their potentially serious side effects. Recreational drugs, some of which are illegal (cocaine, amfetamines), are commonly used by athletes and cause potential ergolytic effects. Overall, these drugs are important for their frequent use and mention in anti-doping laboratories statistics and the media, and their potentially serious adverse effects.

Conclusions: Doping with CNS stimulants is a real public health problem and all sports authorities should participate in its prevention. Dissemination of information is essential to prevent doping in sport and to provide alternatives. Adequate training and education in this domain should be introduced.


Keywords: stimulants; amphetamine; cocaine; ephedrine; doping; sport







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine